On July 8, Bangkaxin® (Esomeprazole Magnesium Enteric-coated Tablets) declared by Qingfeng Pharmaceutical Group and Jiangxi Shanxiang Pharmaceutical Co., Ltd. was approved by NMPA. The successful launch of Bangkaxin® (Esomeprazole magnesium enteric-coated tablets), a high-quality generic drug, once again demonstrates our R&D strength, which also marks Shanxiang Pharmaceutical's esomeprazole magnesium tablets will be among the first tier of the proton pump inhibitor (PPI) market.
┃ Bangkaxin® Esomeprazole Magnesium Enteric-coated Tablets